ABSTRACT
Leukemia, a heterogeneous group of hematologic malignancies, continues to present significant therapeutic challenges owing to persistent issues, such as relapse, drug resistance, and treatment-related toxicity. While traditional research has primarily focused on genetic drivers, there is increasing recognition...
Bin-He Chang, Yong Wang, Zi-Juan Li et al.· Chinese Medical Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.